{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35773325", "DateCompleted": {"Year": "2022", "Month": "07", "Day": "04"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "30"}], "Language": ["eng"], "ELocationID": ["11078", "10.1038/s41598-022-15214-6"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "12", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Jun", "Day": "30"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Artemisinin inhibits neutrophil and macrophage chemotaxis, cytokine production and NET release.", "Pagination": {"StartPage": "11078", "MedlinePgn": "11078"}, "Abstract": {"AbstractText": ["Immune cell chemotaxis to the sites of pathogen invasion is critical for fighting infection, but in life-threatening conditions such as sepsis and Covid-19, excess activation of the innate immune system is thought to cause a damaging invasion of immune cells into tissues and a consequent excessive release of cytokines, chemokines and neutrophil extracellular traps (NETs). In these circumstances, tempering excessive activation of the innate immune system may, paradoxically, promote recovery. Here we identify the antimalarial compound artemisinin as a potent and selective inhibitor of neutrophil and macrophage chemotaxis induced by a range of chemotactic agents. Artemisinin released calcium from intracellular stores in a similar way to thapsigargin, a known inhibitor of the Sarco/Endoplasmic Reticulum Calcium ATPase pump (SERCA), but unlike thapsigargin, artemisinin blocks only the SERCA3 isoform. Inhibition of SERCA3 by artemisinin was irreversible and was inhibited by iron chelation, suggesting iron-catalysed alkylation of a specific cysteine residue in SERCA3 as the mechanism by which artemisinin inhibits neutrophil motility. In murine infection models, artemisinin potently suppressed neutrophil invasion into both peritoneum and lung in vivo and inhibited the release of cytokines/chemokines and NETs. This work suggests that artemisinin may have value as a therapy in conditions such as sepsis and Covid-19 in which over-activation of the innate immune system causes tissue injury that can lead to death."], "CopyrightInformation": "\u00a9 2022. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Wolfson Centre for Age-Related Diseases, King's College London, Guy's Campus, London Bridge, London, SE1 1UL, UK."}], "LastName": "Morad", "ForeName": "Hassan O J", "Initials": "HOJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Wolfson Centre for Age-Related Diseases, King's College London, Guy's Campus, London Bridge, London, SE1 1UL, UK."}, {"Identifier": [], "Affiliation": "Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, P.O. CIMAP, Lucknow, Uttar Pradesh, 226015, India."}], "LastName": "Luqman", "ForeName": "Suaib", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Wolfson Centre for Age-Related Diseases, King's College London, Guy's Campus, London Bridge, London, SE1 1UL, UK."}], "LastName": "Pinto", "ForeName": "Larissa Garcia", "Initials": "LG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Wolfson Centre for Age-Related Diseases, King's College London, Guy's Campus, London Bridge, London, SE1 1UL, UK."}], "LastName": "Cunningham", "ForeName": "Kevin P", "Initials": "KP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Wolfson Centre for Age-Related Diseases, King's College London, Guy's Campus, London Bridge, London, SE1 1UL, UK."}], "LastName": "Vilar", "ForeName": "Bruno", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Immunology and Microbial Sciences, King's College London, Guy's Campus, London Bridge, London, SE1 1UL, UK."}], "LastName": "Clayton", "ForeName": "Georgia", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Queen's Medical Research Institute, Edinburgh BioQuarter, Centre for Inflammation Research, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK."}, {"Identifier": [], "Affiliation": "Department of Intensive Care Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK."}], "LastName": "Shankar-Hari", "ForeName": "Manu", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Wolfson Centre for Age-Related Diseases, King's College London, Guy's Campus, London Bridge, London, SE1 1UL, UK. peter.mcnaughton@kcl.ac.uk."}], "LastName": "McNaughton", "ForeName": "Peter A", "Initials": "PA"}], "GrantList": [{"GrantID": "205006/Z/16/Z", "Acronym": "WT_", "Agency": "Wellcome Trust", "Country": "United Kingdom"}, {"Acronym": "MRC_", "Agency": "Medical Research Council", "Country": "United Kingdom"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Artemisinins"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "67526-95-8", "NameOfSubstance": "Thapsigargin"}, {"RegistryNumber": "EC 7.2.2.10", "NameOfSubstance": "Calcium-Transporting ATPases"}, {"RegistryNumber": "SY7Q814VUP", "NameOfSubstance": "Calcium"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Artemisinins"}, {"QualifierName": ["metabolism"], "DescriptorName": "Calcium"}, {"QualifierName": ["metabolism"], "DescriptorName": "Calcium-Transporting ATPases"}, {"QualifierName": ["drug effects"], "DescriptorName": "Chemotaxis"}, {"QualifierName": ["biosynthesis", "metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": ["metabolism"], "DescriptorName": "Extracellular Traps"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Macrophages"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Neutrophils"}, {"QualifierName": [], "DescriptorName": "Sepsis"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Thapsigargin"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Thwaites RS, et al. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19. Sci. Immunol. 2021 doi: 10.1126/sciimmunol.abg9873.", "ArticleIdList": ["10.1126/sciimmunol.abg9873", "PMC8128298", "33692097"]}, {"Citation": "Jin Y, et al. Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses. 2020 doi: 10.3390/v12040372.", "ArticleIdList": ["10.3390/v12040372", "PMC7232198", "32230900"]}, {"Citation": "Barnes BJ, et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J. Exp. Med. 2020 doi: 10.1084/jem.20200652.", "ArticleIdList": ["10.1084/jem.20200652", "PMC7161085", "32302401"]}, {"Citation": "Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 2018;18:134\u2013147. doi: 10.1038/nri.2017.105.", "ArticleIdList": ["10.1038/nri.2017.105", "28990587"]}, {"Citation": "Col\u00f3n DF, et al. Neutrophil extracellular traps (NETs) exacerbate severity of infant sepsis. Crit Care. 2019;23:113. doi: 10.1186/s13054-019-2407-8.", "ArticleIdList": ["10.1186/s13054-019-2407-8", "PMC6454713", "30961634"]}, {"Citation": "Niethammer P, Grabher C, Look AT, Mitchison TJ. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature. 2009;459:996\u2013999. doi: 10.1038/nature08119.", "ArticleIdList": ["10.1038/nature08119", "PMC2803098", "19494811"]}, {"Citation": "Klyubin IV, Kirpichnikova KM, Gamaley IA. Hydrogen peroxide-induced chemotaxis of mouse peritoneal neutrophils. Eur. J. Cell Biol. 1996;70:347\u2013351.", "ArticleIdList": ["8864663"]}, {"Citation": "Morad H, Luqman S, Tan CH, Swann V, McNaughton PA. TRPM2 ion channels steer neutrophils towards a source of hydrogen peroxide. Sci. Rep. 2021;11:9339. doi: 10.1038/s41598-021-88224-5.", "ArticleIdList": ["10.1038/s41598-021-88224-5", "PMC8085234", "33927223"]}, {"Citation": "Caterina MJ, et al. The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature. 1997;389:816\u2013824. doi: 10.1038/39807.", "ArticleIdList": ["10.1038/39807", "9349813"]}, {"Citation": "Xu H, Delling M, Jun JC, Clapham DE. Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels. Nat. Neurosci. 2006;9:628\u2013635. doi: 10.1038/nn1692.", "ArticleIdList": ["10.1038/nn1692", "16617338"]}, {"Citation": "Partida-Sanchez S, et al. Chemotaxis of mouse bone marrow neutrophils and dendritic cells is controlled by adp-ribose, the major product generated by the CD38 enzyme reaction. J. Immunol. 2007;179:7827\u20137839. doi: 10.4049/jimmunol.179.11.7827.", "ArticleIdList": ["10.4049/jimmunol.179.11.7827", "18025229"]}, {"Citation": "Wang L, et al. Structures and gating mechanism of human TRPM2. Science. 2018 doi: 10.1126/science.aav4809.", "ArticleIdList": ["10.1126/science.aav4809", "PMC6459600", "30467180"]}, {"Citation": "Yu P, et al. Identification of the ADPR binding pocket in the NUDT9 homology domain of TRPM2. J. Gen. Physiol. 2017;149:219\u2013235. doi: 10.1085/jgp.201611675.", "ArticleIdList": ["10.1085/jgp.201611675", "PMC5299621", "28108595"]}, {"Citation": "T\u00f3th B, Csan\u00e1dy L. Identification of direct and indirect effectors of the transient receptor potential melastatin 2 (TRPM2) cation channel. J. Biol. Chem. 2010;285:30091\u201330102. doi: 10.1074/jbc.M109.066464.", "ArticleIdList": ["10.1074/jbc.M109.066464", "PMC2943302", "20650899"]}, {"Citation": "Morris CA, et al. Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration. Malar. J. 2011;10:263. doi: 10.1186/1475-2875-10-263.", "ArticleIdList": ["10.1186/1475-2875-10-263", "PMC3180444", "21914160"]}, {"Citation": "Kouakou YI, et al. Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malaria. Int. J. Infect. Dis. 2019;89:30\u201344. doi: 10.1016/j.ijid.2019.08.030.", "ArticleIdList": ["10.1016/j.ijid.2019.08.030", "31491558"]}, {"Citation": "Pirie NW. The oxidation of sulphydryl compounds by hydrogen peroxide: Catalysis of oxidation of cysteine and glutathione by iron and copper. Biochem. J. 1931;25:1565\u20131579. doi: 10.1042/bj0251565.", "ArticleIdList": ["10.1042/bj0251565", "PMC1260785", "16744723"]}, {"Citation": "Eckstein-Ludwig U, et al. Artemisinins target the SERCA of Plasmodium falciparum. Nature. 2003;424:957\u2013961. doi: 10.1038/nature01813.", "ArticleIdList": ["10.1038/nature01813", "12931192"]}, {"Citation": "Uhlemann AC, et al. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat. Struct. Mol. Biol. 2005;12:628\u2013629. doi: 10.1038/nsmb947.", "ArticleIdList": ["10.1038/nsmb947", "15937493"]}, {"Citation": "Wu WM, Chen YL, Zhai Z, Xiao SH, Wu YL. Study on the mechanism of action of artemether against schistosomes: The identification of cysteine adducts of both carbon-centred free radicals derived from artemether. Bioorg. Med. Chem. Lett. 2003;13:1645\u20131647. doi: 10.1016/s0960-894x(03)00293-2.", "ArticleIdList": ["10.1016/s0960-894x(03)00293-2", "12729632"]}, {"Citation": "Wang D-Y, Wu Y-L. A possible antimalarial action mode of qinghaosu (artemisinin) series compounds Alkylation of reduced glutathione by -centered primary radicals produced from antimalarial compound qinghaosu and 12-(2,4-dimethoxyphenyl)-12-deoxoqinghaosu. Chem. Commun. 2000 doi: 10.1039/B006906J.", "ArticleIdList": ["10.1039/B006906J"]}, {"Citation": "Vaca L. SOCIC: The store-operated calcium influx complex. Cell Calcium. 2010;47:199\u2013209. doi: 10.1016/j.ceca.2010.01.002.", "ArticleIdList": ["10.1016/j.ceca.2010.01.002", "20149454"]}, {"Citation": "Geiszt M, K\u00e1ldi K, Szeber\u00e9nyi JB, Ligeti E. Thapsigargin inhibits Ca2+ entry into human neutrophil granulocytes. Biochem. J. 1995;305(Pt 2):525\u2013528. doi: 10.1042/bj3050525.", "ArticleIdList": ["10.1042/bj3050525", "PMC1136394", "7832770"]}, {"Citation": "Lytton J, Westlin M, Hanley MR. Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J. Biol. Chem. 1991;266:17067\u201317071. doi: 10.1016/S0021-9258(19)47340-7.", "ArticleIdList": ["10.1016/S0021-9258(19)47340-7", "1832668"]}, {"Citation": "Lewis RS. Store-operated calcium channels: from function to structure and back again. Cold Spring Harb. Perspect. Biol. 2020 doi: 10.1101/cshperspect.a035055.", "ArticleIdList": ["10.1101/cshperspect.a035055", "PMC7103539", "31570335"]}, {"Citation": "Ollivier A, et al. Large scale purification of the SERCA inhibitor thapsigargin from Thapsia garganica L. roots using centrifugal partition chromatography. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2013;926:16\u201320. doi: 10.1016/j.jchromb.2013.02.015.", "ArticleIdList": ["10.1016/j.jchromb.2013.02.015", "23537742"]}, {"Citation": "Martin V, et al. Three novel sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) 3 isoforms. Expression, regulation, and function of the membranes of the SERCA3 family. J. Biol. Chem. 2002;277:24442\u201324452. doi: 10.1074/jbc.M202011200.", "ArticleIdList": ["10.1074/jbc.M202011200", "11956212"]}, {"Citation": "Winther AM, et al. Critical roles of hydrophobicity and orientation of side chains for inactivation of sarcoplasmic reticulum Ca2+-ATPase with thapsigargin and thapsigargin analogs. J. Biol. Chem. 2010;285:28883\u201328892. doi: 10.1074/jbc.M110.136242.", "ArticleIdList": ["10.1074/jbc.M110.136242", "PMC2937915", "20551329"]}, {"Citation": "Veras FP, et al. SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology. J. Exp. Med. 2020 doi: 10.1084/jem.20201129.", "ArticleIdList": ["10.1084/jem.20201129", "PMC7488868", "32926098"]}, {"Citation": "Calvano SE, et al. A network-based analysis of systemic inflammation in humans. Nature. 2005;437:1032\u20131037. doi: 10.1038/nature03985.", "ArticleIdList": ["10.1038/nature03985", "16136080"]}, {"Citation": "Ismail HM, et al. Artemisinin activity-based probes identify multiple molecular targets within the asexual stage of the malaria parasites Plasmodium falciparum 3D7. Proc. Natl. Acad. Sci. USA. 2016;113:2080\u20132085. doi: 10.1073/pnas.1600459113.", "ArticleIdList": ["10.1073/pnas.1600459113", "PMC4776496", "26858419"]}, {"Citation": "Wang J, et al. Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum. Nat. Commun. 2015;6:10111. doi: 10.1038/ncomms10111.", "ArticleIdList": ["10.1038/ncomms10111", "PMC4703832", "26694030"]}, {"Citation": "Price RN, et al. The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand. Antimicrob. Agents Chemother. 1999;43:2943\u20132949. doi: 10.1128/aac.43.12.2943.", "ArticleIdList": ["10.1128/aac.43.12.2943", "PMC89592", "10582887"]}, {"Citation": "Meshnick SR, et al. Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu) Antimicrob. Agents Chemother. 1993;37:1108\u20131114. doi: 10.1128/aac.37.5.1108.", "ArticleIdList": ["10.1128/aac.37.5.1108", "PMC187911", "8517699"]}, {"Citation": "Cardi D, et al. Purified E255L mutant SERCA1a and purified PfATP6 are sensitive to SERCA-type inhibitors but insensitive to artemisinins. J. Biol. Chem. 2010;285:26406\u201326416. doi: 10.1074/jbc.M109.090340.", "ArticleIdList": ["10.1074/jbc.M109.090340", "PMC2924071", "20530490"]}, {"Citation": "Krishna S, Pulcini S, Moore CM, Teo BH, Staines HM. Pumped up: Reflections on PfATP6 as the target for artemisinins. Trends Pharmacol. Sci. 2014;35:4\u201311. doi: 10.1016/j.tips.2013.10.007.", "ArticleIdList": ["10.1016/j.tips.2013.10.007", "24268763"]}, {"Citation": "Dyla M, Basse Hansen S, Nissen P, Kjaergaard M. Structural dynamics of P-type ATPase ion pumps. Biochem. Soc. Trans. 2019;47:1247\u20131257. doi: 10.1042/bst20190124.", "ArticleIdList": ["10.1042/bst20190124", "31671180"]}, {"Citation": "Cao, H. et al. Effect of artemisinin on lung injury in septic rats. 951\u2013954."}, {"Citation": "Cao TH, et al. Artesunate protects against sepsis-induced lung injury via heme oxygenase-1 modulation. Inflammation. 2016;39:651\u2013662. doi: 10.1007/s10753-015-0290-2.", "ArticleIdList": ["10.1007/s10753-015-0290-2", "26627481"]}, {"Citation": "Ho WE, et al. Anti-malarial drug artesunate ameliorates oxidative lung damage in experimental allergic asthma. Free Radical Biol. Med. 2012;53:498\u2013507. doi: 10.1016/j.freeradbiomed.2012.05.021.", "ArticleIdList": ["10.1016/j.freeradbiomed.2012.05.021", "22634146"]}, {"Citation": "Huang XT, et al. Dihydroartemisinin attenuates lipopolysaccharide-induced acute lung injury in mice by suppressing NF-\u03baB signaling in an Nrf2-dependent manner. Int. J. Mol. Med. 2019;44:2213\u20132222. doi: 10.3892/ijmm.2019.4387.", "ArticleIdList": ["10.3892/ijmm.2019.4387", "PMC6844637", "31661121"]}, {"Citation": "Jiang L, Zhang Y, Sun Y, Hu L, Gao D. Artesunate attenuates lung injury in paraquat-intoxicated rats via downregulation of inflammatory cytokines. Clin. Lab. 2015;61:1601\u20131607. doi: 10.7754/clin.lab.2015.141244.", "ArticleIdList": ["10.7754/clin.lab.2015.141244", "26731983"]}, {"Citation": "Liu Z, Qu M, Yu L, Song P, Chang Y. Artesunate inhibits renal ischemia-reperfusion-mediated remote lung inflammation through attenuating ROS-induced activation of NLRP3 inflammasome. Inflammation. 2018;41:1546\u20131556. doi: 10.1007/s10753-018-0801-z.", "ArticleIdList": ["10.1007/s10753-018-0801-z", "29730819"]}, {"Citation": "Liu Z, Zhang J, Li S, Jiang J. Artesunate inhibits renal ischemia reperfusion-stimulated lung inflammation in rats by activating HO-1 pathway. Inflammation. 2018;41:114\u2013121. doi: 10.1007/s10753-017-0669-3.", "ArticleIdList": ["10.1007/s10753-017-0669-3", "28921399"]}, {"Citation": "Ng DS, et al. Anti-malarial drug artesunate protects against cigarette smoke-induced lung injury in mice. Phytomedicine. 2014;21:1638\u20131644. doi: 10.1016/j.phymed.2014.07.018.", "ArticleIdList": ["10.1016/j.phymed.2014.07.018", "25442271"]}, {"Citation": "Ledford H. International COVID-19 trial to restart with focus on immune responses. Nature. 2021 doi: 10.1038/d41586-021-01090-z.", "ArticleIdList": ["10.1038/d41586-021-01090-z", "33963326"]}, {"Citation": "WHO\u2019s Solidarity clinical trial enters a new phase with three new candidate drugs, <https://www.who.int/news/item/11-08-2021-who-s-solidarity-clinical-trial-enters-a-new-phase-with-three-new-candidate-drugs> (2021)."}, {"Citation": "Solidarity Trial Plus: An international randomized trial of additional treatments for COVID-19 in hospitalized patients who are all receiving the local standard of care, <https://www.isrctn.com/ISRCTN18066414> (2021)."}, {"Citation": "Cunningham KP, et al. Characterization and regulation of wild-type and mutant TASK-1 two pore domain potassium channels indicated in pulmonary arterial hypertension. J. Physiol. 2019;597:1087\u20131101. doi: 10.1113/jp277275.", "ArticleIdList": ["10.1113/jp277275", "PMC6376074", "30365877"]}, {"Citation": "Wu KD, Lytton J. Molecular cloning and quantification of sarcoplasmic reticulum Ca(2+)-ATPase isoforms in rat muscles. Am. J. Physiol. 1993;264:C333\u2013341. doi: 10.1152/ajpcell.1993.264.2.C333.", "ArticleIdList": ["10.1152/ajpcell.1993.264.2.C333", "8447366"]}, {"Citation": "Lytton J, MacLennan DH. Molecular cloning of cDNAs from human kidney coding for two alternatively spliced products of the cardiac Ca2+-ATPase gene. J. Biol. Chem. 1988;263:15024\u201315031. doi: 10.1016/S0021-9258(18)68141-4.", "ArticleIdList": ["10.1016/S0021-9258(18)68141-4", "2844796"]}, {"Citation": "Poch E, et al. Functional characterization of alternatively spliced human SERCA3 transcripts. Am. J. Physiol. 1998;275:C1449\u20131458. doi: 10.1152/ajpcell.1998.275.6.C1449.", "ArticleIdList": ["10.1152/ajpcell.1998.275.6.C1449", "9843705"]}, {"Citation": "Lainez S, Tsantoulas C, Biel M, McNaughton PA. HCN3 ion channels: Roles in sensory neuronal excitability and pain. J. Physiol. 2019;597:4661\u20134675. doi: 10.1113/jp278211.", "ArticleIdList": ["10.1113/jp278211", "31290157"]}, {"Citation": "Pinto LG, et al. Joint production of IL-22 participates in the initial phase of antigen-induced arthritis through IL-1\u03b2 production. Arthritis Res. Ther. 2015;17:235. doi: 10.1186/s13075-015-0759-2.", "ArticleIdList": ["10.1186/s13075-015-0759-2", "PMC4556214", "26330334"]}, {"Citation": "Czaikoski PG, et al. Neutrophil extracellular traps induce organ damage during experimental and clinical sepsis. PLoS ONE. 2016;11:e0148142. doi: 10.1371/journal.pone.0148142.", "ArticleIdList": ["10.1371/journal.pone.0148142", "PMC4743982", "26849138"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "2", "Day": "7"}, {"Year": "2022", "Month": "6", "Day": "21"}, {"Year": "2022", "Month": "6", "Day": "30", "Hour": "23", "Minute": "20"}, {"Year": "2022", "Month": "7", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "30"}], "PublicationStatus": "epublish", "ArticleIdList": ["35773325", "PMC9245885", "10.1038/s41598-022-15214-6", "10.1038/s41598-022-15214-6"]}}], "PubmedBookArticle": []}